Purchases and Sales Made in Q4 2022 in Inozyme Pharma, Inc. (INZY)
This table provides information about the institutional ownership of Inozyme Pharma, Inc. (INZY) during Q4 2022. The information is specifically focused on institutions that hold shares of Inozyme Pharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
BUY
|
- |
503K+ 19.39% |
$529K - $1.42M
|
3.1M
$9.36M
|
|
|
Feb 13, 2023
Q4 2022
|
Affinity Asset Advisors, LLC
New York, NY |
BUY
|
- |
500KNew |
$525K - $1.41M
|
500K
$1.51M
|
|
|
Feb 14, 2023
Q4 2022
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
BUY
|
- |
450K+ 38.3% |
$473K - $1.27M
|
1.63M
$4.91M
|
|
|
Feb 14, 2023
Q4 2022
|
Rock Springs Capital Management LP
Baltimore, MD |
BUY
|
- |
278K+ 9.92% |
$292K - $785K
|
3.09M
$9.32M
|
|
|
Feb 13, 2023
Q4 2022
|
Chi Advisors LLC
New York, NY |
BUY
|
- |
209K+ 10.45% |
$219K - $588K
|
2.2M
$6.66M
|
|
|
Feb 13, 2023
Q4 2022
|
Overbrook Management Corp
New York, NY |
BUY
|
- |
150K+ 216.37% |
$158K - $423K
|
219K
$662K
|
|
|
Feb 14, 2023
Q4 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
128K+ 75.07% |
$134K - $360K
|
298K
$900K
|
|
|
Feb 13, 2023
Q4 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
104K+ 66.6% |
$109K - $292K
|
259K
$782K
|
|
|
Feb 14, 2023
Q4 2022
|
Bank Of New York Mellon Corp
New York, NY |
BUY
|
- |
20.2KNew |
$21.3K - $57.1K
|
20.2K
$61.1K
|
|
|
Feb 03, 2023
Q4 2022
|
Parallel Advisors, LLC
|
BUY
|
- |
19.9KNew |
$20.9K - $56K
|
19.9K
$60K
|
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
11.9KNew |
$12.5K - $33.6K
|
11.9K
$36K
|
|
|
Feb 13, 2023
Q4 2022
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
5.64K+ 13.99% |
$5.92K - $15.9K
|
45.9K
$139K
|
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
4.18K+ 142.74% |
$4.39K - $11.8K
|
7.11K
$21.5K
|
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
3.6KNew |
$3.78K - $10.1K
|
3.6K
$10.9K
|
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
BUY
|
- |
2.83KNew |
$2.98K - $7.99K
|
2.83K
$8.56K
|
|
|
Feb 10, 2023
Q4 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
559+ 0.04% |
$587 - $1.58K
|
1.34M
$4.06M
|
|
|
Feb 02, 2023
Q4 2022
|
Simplex Trading, LLC
|
BUY
|
- |
137New |
$144 - $386
|
137
$414
|
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
5+ 3.18% |
$5.25 - $14.1
|
162
$489
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Barclays PLC
London, X0 |
SELL
|
- |
-130- 2.03% |
$137 - $367
|
6.27K
$18.9K
|
|
|
Feb 13, 2023
Q4 2022
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-152- 9.92% |
$160 - $429
|
1.38K
$4.17K
|
|
|
Feb 13, 2023
Q4 2022
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-559- 0.24% |
$587 - $1.58K
|
233K
$704K
|
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-581- 4.65% |
$610 - $1.64K
|
11.9K
$36K
|
|
|
Feb 14, 2023
Q4 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-800- 6.07% |
$840 - $2.26K
|
12.4K
$37.4K
|
|
|
Feb 13, 2023
Q4 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-2.21K- 0.52% |
$2.32K - $6.22K
|
426K
$1.29M
|
|
|
Feb 09, 2023
Q4 2022
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-4.84K- 17.88% |
$5.08K - $13.6K
|
22.2K
$67.1K
|
|
|
Feb 10, 2023
Q4 2022
|
Nea Management Company, LLC
Timonium, MD |
SELL
|
- |
-6.69K- 0.27% |
$7.02K - $18.9K
|
2.44M
$7.36M
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-9.14K- 41.01% |
$9.59K - $25.8K
|
13.1K
$39.7K
|
|
|
Feb 14, 2023
Q4 2022
|
State Of Wisconsin Investment Board
Madison, WI |
SELL
|
- |
-11.1K- 22.75% |
$11.7K - $31.3K
|
37.7K
$114K
|
|
|
Feb 14, 2023
Q4 2022
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-24.9K- 15.03% |
$26.1K - $70.1K
|
141K
$425K
|
|
|
Feb 14, 2023
Q4 2022
|
Bio Impact Capital LLC
Cambridge, MA |
SELL
|
- |
-431K- 65.14% |
$452K - $1.21M
|
231K
$696K
|